Compounded vs. Research Peptides: How to Verify a Peptide Pharmacy
Eight questions to ask a peptide pharmacy, the red flags to avoid, and why research-use-only and prescription-compounded products are not equivalent.
By Gulf Breeze Apothecary
Published November 4, 2026
The short answer
A legitimate peptide pharmacy fills a prescription written for you, uses raw peptide from an FDA-registered manufacturer with full test results, puts a single active ingredient in each product, and labels it "This is a compounded drug product. Not for resale." A "research use only" seller does none of that. Since October 2026, HHS's peptide policy spells out these standards for six peptides, so you can check a pharmacy against them.
Compounded vs. research-use-only, side by side
The name on the vial can be identical. Everything behind it is different.
| Item | Pharmacy-compounded (under the HHS policy) | "Research use only" seller |
|---|---|---|
| Prescription | Required, written for you | None |
| Who prepares it | A state-licensed pharmacy | Unregulated vendor, often overseas |
| Raw material source | FDA-registered, CGMP-compliant original manufacturer, named on the certificate | Usually undisclosed |
| Testing | More than 15 test categories, including sequence identity, endotoxin, heavy metals, microbes and impurities | Typically purity and mass only |
| Ingredients per product | One active ingredient | Blends common |
| Label | "This is a compounded drug product. Not for resale." plus side-effect reporting instructions | "Not for human consumption" |
| Side-effect reporting | Pharmacy reports serious events to FDA MedWatch | None |
| Pharmacist counseling | Yes | No |
Source: HHS policy, conditions and testing standard (opens in a new tab). HHS itself framed the policy as a way to move patients away from research-use-only peptides made by foreign suppliers.
8 questions to ask any peptide pharmacy
A legitimate pharmacy can answer all eight quickly and without hedging.
- Are you a state-licensed 503A pharmacy, and are you licensed in my state? Ask for the license number and check it with your state board of pharmacy. (GBA's licensed states)
- Do you need a prescription written for me? The answer must be yes. The HHS policy covers only patient-specific prescriptions.
- Who manufactured the raw peptide? The original manufacturer, not just a distributor, must be FDA-registered and CGMP-compliant, with its facility named on the certificate of analysis.
- Can my prescriber see the certificate of analysis? It should show identity by more than one method, purity, endotoxin, microbes, heavy metals and residual solvents, and state it is intended for human drug compounding.
- Is this peptide and route covered by the HHS policy? For example, Semax only as a nasal spray, KPV only topical or oral, TB-500 and MOTS-c only injected.
- Does each product contain a single active ingredient? Any blend is outside the policy, including a listed peptide mixed with another active such as semaglutide. Blends such as BPC-157/TB-500 are not allowed.
- What will the label say? Look for "This is a compounded drug product. Not for resale." and instructions for reporting side effects.
- Will a pharmacist counsel me, and how do I report a problem? The pharmacy must report serious adverse events to FDA MedWatch.
Source: HHS policy, conditions 1–10 (opens in a new tab).
A shortcut: LegitScript certification
LegitScript is an independent organization that certifies healthcare businesses, including pharmacies. Since November 2, 2026, its reviews check peptide offerings against the HHS policy: the ingredient, formulation, route, compounding facility and supply chain (LegitScript (opens in a new tab)). Offering peptides outside the policy remains a barrier to certification. You can check any website's status with LegitScript's certification lookup (opens in a new tab).
Gulf Breeze Apothecary is LegitScript-certified. Certification is a strong signal, not a substitute for the eight questions above.
Why no pharmacy can fill the "Wolverine stack"
The popular BPC-157 and TB-500 blend is outside the HHS policy, even though both peptides are on the list. Condition 7 says each compounded product may contain only a single active ingredient. HHS's reason: when a product has one ingredient, any side effect can be traced to that ingredient, which is the point of the policy's safety reporting.
If a seller offers a BPC-157/TB-500 blend as a "compliant" or "pharmacy-grade" product, that is a red flag. A prescriber may still prescribe each peptide separately, and a pharmacy may fill each as its own product, if both meet the policy's other conditions.
Red flags
Walk away if a seller or clinic does any of these:
- Ships peptides without a prescription written for you
- Labels vials "for research use only" or "not for human consumption" while giving dosing advice
- Offers blends or "stacks" in one vial and calls them pharmacy-compliant
- Sells peptides outside the HHS list (anything other than BPC-157, TB-500, Epitalon, MOTS-c, KPV and Semax) and says the October 2026 policy covers them, or offers peptides that remain ineligible for compounding, such as retatrutide or cagrilintide
- Offers routes the policy excludes, such as injectable Semax or injectable KPV
- Won't name the original manufacturer or share a certificate of analysis
- Promises results such as healing, fat loss or longer life
- Claims these peptides are "FDA-approved"
- Ships to your state without being licensed there
For prescribers
To stay inside the HHS policy, each prescription should name one patient, one listed peptide in its covered form, and a covered route. Expect the pharmacy to:
- Decline blends and routes outside Appendix B
- Require documented human bioavailability before filling an oral BPC-157 or KPV formulation
- Dispense injectables only with an FDA-cleared syringe
- Report serious adverse events and quality issues to FDA MedWatch and the relevant states
The policy covers 503A compounding for named patients. It does not extend to 503B office stock. State board rules still apply.
Prescribers can visit For Providers for general pharmacy information. Product availability and turnaround are confirmed individually.
Frequently asked questions
Are research peptides legal now? The HHS policy does not address research-use-only sales at all. It covers only licensed pharmacies compounding for patients with prescriptions.
Is a compounded peptide the same as a research peptide with a good certificate? No. A compounded peptide must come from an FDA-registered, CGMP-compliant manufacturer, pass a much broader testing standard, and be dispensed under a prescription with safety reporting.
What is a certificate of analysis? A lab report for a specific batch of raw material. Under the policy it must name the original manufacturer and facility and include identity, purity, contamination and impurity results.
Can I get a peptide blend from a pharmacy? Not under the HHS policy. Each product may contain only a single active ingredient, so no peptide blends and no peptide mixed with another active.
How do I check a pharmacy's license? Search your state board of pharmacy's license lookup. For Florida pharmacies, use the Florida Department of Health license verification site.
Sources
- HHS Enforcement Discretion Policy, conditions, appendices and testing standard (opens in a new tab)
- Federal Register notice, FR Doc. 2026-22192 (opens in a new tab)
- Frier Levitt: HHS peptide compounding enforcement discretion policy (opens in a new tab)
- BioSpace: HHS clears compounding pharmacies to make 6 unapproved peptides (opens in a new tab)
Related: Are Peptides Legal Now? · The 6 HHS-Covered Peptides
General education only, not medical or legal advice. Compounded medications are not FDA-approved and require a prescription. Talk with your prescriber about whether any medication is right for you.